alecman's BlogSend MessagePlease Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.Gilead's EarningApr. 30, 2013 7:25 PM ET|Includes: Gilead Sciences, Inc. (GILD) Gilead(NASDAQ:GILD) - I think the company will beat earning estimate by +.02 cents. The R&D cost will be high due to phase III trial of HCV. The guidance will beat analysts estimates. Disclosure: I am long GILD.